Microbiome 2.0: Leading BioSciences Focuses On The 'Gastrobiome'
Emerging Company Profile: Firms that label themselves as microbiome companies have mushroomed in the past couple of years. Leading BioSciences likes to think it's working on "microbiome 2.0" and has filed a trademark application for the term "gastrobiome" to express that differentiation.
You may also be interested in...
See how much the CEOs and R&D heads of the world’s biggest pharma companies get paid, and how those companies are performing.
Merck & Co is gradually catching up with Roche in PD-1/L1 first-line triple-negative breast cancer treatment, but its presentation at ASCO on Keynote-355 includes mixed PFS results. Overall survival data will be key to Keytruda’s competitiveness.
INFOGRAPHIC: A snapshot of the compensation packages granted to the chiefs of the world’s biggest pharma companies, along with key performance stats for the businesses they lead.